Journal article

The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic

Wen Li, Na Zhao, Xiaona Yan, Siyun Zou, Huan Wang, Yulong Li, Xiuying Xu, Xiangdong Du, Lan Zhang, Qinge Zhang, Teris Cheung, Gabor S Ungvari, Chee H Ng, Yu-Tao Xiang

TRANSLATIONAL PSYCHIATRY | SPRINGERNATURE | Published : 2021

Abstract

The impact of the COVID-19 pandemic on clinically stable older patients with psychiatric disorders is unclear. This study examined the prevalence of depressive and anxiety symptoms, and their associations with quality of life (QOL) in clinically stable older patients with psychiatric disorders during the COVID-19 pandemic. This was a multicenter, cross-sectional study. Depressive and anxiety symptoms, insomnia, pain, and QOL were assessed with standardized instruments. A total of 1063 patients were included. The prevalence of depressive and anxiety symptoms, and combined depressive and anxiety symptoms were 62.3% (95%CI = 59.4-65.2%), 52.4% (95%CI = 49.3-55.4%), and 45.9% (95%CI = 42.9-48.9%..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Science and Technology Major Project for investigational new drug


Awarded by Beijing Municipal Science and Technology Commission


Awarded by University of Macau


Awarded by Suzhou Key Medical Center for Psychiatric Diseases


Funding Acknowledgements

The study was supported by the National Science and Technology Major Project for investigational new drug (2018ZX09201-014), the Beijing Municipal Science and Technology Commission (No. Z181100001518005), the University of Macau (MYRG2019-00066-FHS), and the Suzhou Key Medical Center for Psychiatric Diseases (Szzx201509).